NURIX THERAPEUTICS, INC. (NRIX) Net margin 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) net profit margin by fiscal year — reported net income divided by reported revenue.
-314.9%FY2025 · since FY2019: -69.7% → -314.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -314.9% | +39.9 pp |
| FY2024 | -354.9% | -167.9 pp |
| FY2023 | -187.0% | +280.0 pp |
| FY2022 | -466.9% | -73.0 pp |
| FY2021 | -393.9% | -151.3 pp |
| FY2020 | -242.7% | -172.9 pp |
| FY2019 | -69.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice